Sector
Israeli biotech startups
11 Israeli biotech startups are in the directory, with 11 publicly reported funding rounds totalling $164.8M. The most recent was Undecimal Bio’s Seed round on Oct 13, 2026.
- Companies
- 11
- Funding rounds
- 11
- Raised
- $164.8M
- Latest round
- Oct 13, 2026
Companies
| Undecimal BioAI-enabled platform for delivering RNA interference medicines to specific cell types; spun out of Eleven Therapeutics. | Cambridge and Tel Aviv | Oct 13, 2026Seed | $18M | |
| RemepyHybrid drugs pairing prescription medicine with AI-driven apps; Parkinsons Phase III prep | Ramat Gan | 2022 | Aug 12, 2026Series A | $36M |
| SplisenseAntisense-oligonucleotide therapies for genetic diseases caused by splicing mutations, including cystic fibrosis | Jerusalem | Jun 16, 2026Undisclosed stage | $13M | |
| PhytolonFermentation-based natural food colors replacing synthetic dyes | 2018 | May 26, 2026Series B | $23.6M | |
| SuperMeatCultivated chicken producer growing real meat from cells | Tel Aviv | May 12, 2026Series A | $6M | |
| MSICS PharmaMedical-grade psilocybin production and clinical trials for PTSD, depression, OCD | May 3, 2026Undisclosed stage | $3.6M | ||
| PolyrizonHydrogel nasal-spray barriers against allergens and viruses, plus intranasal drug delivery | Raanana | Apr 7, 2026Undisclosed stage | $3.5M | |
| Scala BiodesignComputational protein-engineering software for drug developers, from Weizmann research | Rehovot | Mar 31, 2026Series A | $16M | |
| Kailo PharmaDrug development to weaken traumatic memories for PTSD, from University of Haifa research | Mar 22, 2026Undisclosed stage | $2.1M | ||
| Starget PharmaSmart targeted radioligands for precision cancer therapy | Ness Ziona | 2019 | Feb 18, 2026Series A | $18M |
| Converge BioAI platform for drug discovery, antibody design and protein optimization | 2024 | Jan 13, 2026Series A | $25M |
Most active biotech investors
| 1 | Saras Capital | 2 | 0 | $43M |
| 2 | TLV Partners | 2 | 0 | $41M |
| 3 | Israel Innovation Authority | 2 | 0 | $18.1M |
| 4 | O.G. Venture Partners | 1 | 1 | $36M |
| 5 | Bessemer Venture Partners | 1 | 1 | $25M |
| 6 | 4BIO Capital | 1 | 1 | $18M |
| 7 | Ilex Medical | 1 | 1 | $18M |
| 8 | IQ Capital | 1 | 1 | $18M |
| 9 | Grove Ventures | 1 | 1 | $16M |
| 10 | NGT Healthcare II | 1 | 1 | $2.1M |
How many Israeli biotech startups are there?
11 Israeli biotech companies have at least one funding round verified against a public report in this directory. Companies without a reported round are not counted.
How much have Israeli biotech startups raised?
Rounds with a disclosed amount total $164.8M across 11 rounds. Undisclosed rounds are not included in the total.
Which Israeli biotech startups raised money most recently?
The latest reported rounds were raised by Undecimal Bio, Remepy and Splisense.
Who invests most in Israeli biotech startups?
By number of rounds joined: Saras Capital (2 rounds), TLV Partners (2 rounds) and Israel Innovation Authority (2 rounds).